Winthrop Partners - WNY’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$8.41K Hold
50
0.01% 256
2019
Q2
$8.37K Hold
50
0.01% 200
2019
Q1
$7.38K Hold
50
0.01% 205
2018
Q4
$6.68K Hold
50
0.01% 214
2018
Q3
$9.52K Hold
50
0.01% 245
2018
Q2
$8.34K Hold
50
0.01% 264
2018
Q1
$8.09K Buy
+50
New +$8.39K 0.01% 351

Other funds holding AGN

Winthrop Partners - WNY's AGN Position: Q3 2019 in Review

Winthrop Partners - WNY held its Allergan plc (AGN) position steady in Q3 2019 at 50 shares worth $8.41K. The position accounts for 0.01% of the portfolio, ranked #256.

Winthrop Partners - WNY first reported a position in AGN in Q1 2018 and has held it in 7 quarters since. The position peaked at $9.52K in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Winthrop Partners - WNY held 50 shares of Allergan plc worth $8.41K as of Q3 2019.
  • Winthrop Partners - WNY left its Allergan plc share count unchanged in Q3 2019.
  • Allergan plc made up 0.01% of Winthrop Partners - WNY's portfolio in Q3 2019, its #256 holding.
  • Winthrop Partners - WNY first reported a position in Allergan plc in Q1 2018 and has held it in 7 quarters since.
  • Winthrop Partners - WNY's Allergan plc position peaked at $9.52K in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.